Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pediatric Obesity | 2 | 2023 | 32 | 0.890 |
Why?
|
| Prediabetic State | 1 | 2023 | 42 | 0.750 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2023 | 193 | 0.720 |
Why?
|
| Metabolic Syndrome | 1 | 2023 | 122 | 0.700 |
Why?
|
| Insulin Resistance | 2 | 2023 | 379 | 0.690 |
Why?
|
| Sebaceous Glands | 7 | 2001 | 28 | 0.650 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 188 | 0.610 |
Why?
|
| Vitamin D Deficiency | 1 | 2019 | 107 | 0.560 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1229 | 0.430 |
Why?
|
| Thymus Hyperplasia | 1 | 2014 | 3 | 0.420 |
Why?
|
| Graves Disease | 1 | 2014 | 36 | 0.410 |
Why?
|
| Endocrinology | 1 | 2014 | 50 | 0.390 |
Why?
|
| Pediatrics | 1 | 2014 | 385 | 0.300 |
Why?
|
| Androgens | 3 | 2000 | 162 | 0.290 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 6 | 2007 | 123 | 0.220 |
Why?
|
| Child | 4 | 2023 | 7355 | 0.180 |
Why?
|
| Hormones | 2 | 2007 | 136 | 0.170 |
Why?
|
| Hair Follicle | 1 | 2000 | 28 | 0.160 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2019 | 4 | 0.160 |
Why?
|
| Puberty, Delayed | 1 | 2019 | 18 | 0.160 |
Why?
|
| Amenorrhea | 1 | 2019 | 27 | 0.160 |
Why?
|
| Mullerian Ducts | 1 | 2019 | 20 | 0.150 |
Why?
|
| Somatomedins | 1 | 1999 | 28 | 0.150 |
Why?
|
| Sunlight | 1 | 2019 | 27 | 0.150 |
Why?
|
| Human Growth Hormone | 1 | 1999 | 51 | 0.150 |
Why?
|
| Vitamins | 1 | 2019 | 85 | 0.140 |
Why?
|
| Dietary Supplements | 1 | 2019 | 131 | 0.140 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 1997 | 9 | 0.130 |
Why?
|
| Genitalia, Male | 1 | 1997 | 24 | 0.130 |
Why?
|
| Genitalia, Female | 1 | 1997 | 26 | 0.130 |
Why?
|
| Vitamin D | 1 | 2019 | 272 | 0.130 |
Why?
|
| Adolescent | 4 | 2019 | 9606 | 0.130 |
Why?
|
| Thiazolidinediones | 4 | 2005 | 77 | 0.120 |
Why?
|
| Isoenzymes | 1 | 1997 | 272 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 646 | 0.120 |
Why?
|
| Crohn Disease | 1 | 2022 | 808 | 0.120 |
Why?
|
| Colitis, Ulcerative | 1 | 2022 | 800 | 0.120 |
Why?
|
| Hair | 1 | 1995 | 55 | 0.110 |
Why?
|
| Skin | 3 | 2007 | 578 | 0.110 |
Why?
|
| Humans | 13 | 2023 | 93515 | 0.110 |
Why?
|
| PPAR gamma | 2 | 2005 | 75 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 589 | 0.100 |
Why?
|
| Transcription Factors | 5 | 2001 | 1691 | 0.100 |
Why?
|
| Female | 8 | 2023 | 48702 | 0.090 |
Why?
|
| Risk Factors | 1 | 2023 | 5899 | 0.090 |
Why?
|
| Asthma | 1 | 2019 | 1039 | 0.090 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2010 | 19 | 0.080 |
Why?
|
| Chromosomes, Human, Y | 1 | 2010 | 26 | 0.080 |
Why?
|
| Mosaicism | 1 | 2010 | 73 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1546 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2001 | 1245 | 0.070 |
Why?
|
| Cell Division | 2 | 2001 | 693 | 0.070 |
Why?
|
| Cell Differentiation | 5 | 2005 | 1621 | 0.070 |
Why?
|
| Rats | 5 | 2001 | 4072 | 0.060 |
Why?
|
| Skin Physiological Phenomena | 1 | 2007 | 18 | 0.060 |
Why?
|
| Hyperinsulinism | 1 | 2007 | 45 | 0.060 |
Why?
|
| Dihydrotestosterone | 3 | 1999 | 28 | 0.060 |
Why?
|
| Response Elements | 1 | 2004 | 65 | 0.050 |
Why?
|
| Adipocytes | 1 | 2005 | 169 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 290 | 0.050 |
Why?
|
| Adult | 1 | 2023 | 27918 | 0.050 |
Why?
|
| Menarche | 1 | 2022 | 30 | 0.050 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2001 | 47 | 0.040 |
Why?
|
| Epoprostenol | 1 | 2001 | 46 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2005 | 443 | 0.040 |
Why?
|
| Retinoids | 1 | 2000 | 18 | 0.040 |
Why?
|
| Alopecia | 1 | 2000 | 35 | 0.040 |
Why?
|
| Hirsutism | 1 | 2000 | 53 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 740 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2000 | 121 | 0.040 |
Why?
|
| Acne Vulgaris | 1 | 2000 | 33 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 1117 | 0.040 |
Why?
|
| Animals | 9 | 2007 | 28155 | 0.040 |
Why?
|
| Obesity | 1 | 2007 | 1018 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2000 | 439 | 0.040 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1999 | 32 | 0.040 |
Why?
|
| Hypogonadism | 1 | 2019 | 43 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2019 | 71 | 0.040 |
Why?
|
| Sebum | 1 | 1999 | 6 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2001 | 2850 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 1234 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1999 | 116 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1999 | 1914 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2000 | 292 | 0.040 |
Why?
|
| Epididymis | 1 | 1997 | 19 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 988 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1997 | 244 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1997 | 126 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1997 | 384 | 0.030 |
Why?
|
| Ovary | 1 | 1997 | 254 | 0.030 |
Why?
|
| Antibodies | 1 | 1997 | 348 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2019 | 565 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2001 | 2026 | 0.030 |
Why?
|
| Thiazoles | 3 | 2001 | 124 | 0.030 |
Why?
|
| Male | 5 | 2001 | 44557 | 0.030 |
Why?
|
| Prostate | 1 | 1997 | 416 | 0.030 |
Why?
|
| Retinoid X Receptors | 2 | 2004 | 38 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 1799 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 2544 | 0.020 |
Why?
|
| Liver | 1 | 1997 | 1210 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3830 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 2441 | 0.020 |
Why?
|
| Turner Syndrome | 1 | 2010 | 27 | 0.020 |
Why?
|
| Karyotyping | 1 | 2010 | 222 | 0.020 |
Why?
|
| Chromans | 2 | 2001 | 28 | 0.020 |
Why?
|
| Drug Synergism | 2 | 2001 | 315 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2010 | 350 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2004 | 2910 | 0.020 |
Why?
|
| Pyrimidines | 2 | 2001 | 384 | 0.020 |
Why?
|
| Lipids | 2 | 2000 | 278 | 0.020 |
Why?
|
| Cushing Syndrome | 1 | 2007 | 25 | 0.020 |
Why?
|
| Puberty, Precocious | 1 | 2007 | 31 | 0.020 |
Why?
|
| Skin Aging | 1 | 2007 | 31 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 9099 | 0.020 |
Why?
|
| Steroids | 1 | 2007 | 168 | 0.010 |
Why?
|
| Gene Expression | 2 | 2000 | 1301 | 0.010 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2005 | 24 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2007 | 174 | 0.010 |
Why?
|
| 3T3-L1 Cells | 1 | 2005 | 35 | 0.010 |
Why?
|
| Mice | 3 | 2005 | 12269 | 0.010 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2004 | 4 | 0.010 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2004 | 8 | 0.010 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2005 | 26 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2004 | 65 | 0.010 |
Why?
|
| Dimerization | 1 | 2004 | 148 | 0.010 |
Why?
|
| Wound Healing | 1 | 2007 | 373 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2004 | 192 | 0.010 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2005 | 158 | 0.010 |
Why?
|
| RNA Interference | 1 | 2005 | 379 | 0.010 |
Why?
|
| Ligands | 1 | 2005 | 476 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2010 | 3829 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 555 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 880 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 729 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 379 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 1133 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 2012 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 1534 | 0.010 |
Why?
|
| Receptors, Calcitriol | 1 | 2001 | 131 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 295 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 1768 | 0.010 |
Why?
|
| Dermatitis | 1 | 2000 | 34 | 0.010 |
Why?
|
| Epidermis | 1 | 2000 | 103 | 0.010 |
Why?
|
| Stem Cells | 1 | 2001 | 387 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 159 | 0.010 |
Why?
|
| Reference Values | 1 | 2000 | 608 | 0.010 |
Why?
|
| Linoleic Acid | 1 | 1998 | 5 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 5410 | 0.010 |
Why?
|
| Antioxidants | 1 | 1999 | 231 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 1985 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 2220 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1999 | 700 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2000 | 2121 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 3169 | 0.010 |
Why?
|